Toutes les informations sur:

Nom	Summit Pharmaceuticals Europe Limited
Adresse	Vintners' Place 68 Upper Thames Street London EC4V 3BJ
VAT ID (Numéro de TVA)	no VAT ID available
Société Numéro de Registre	04217656 Show on Companies House
Statut de Société	Dissolved
Fondé	16 mai 2001
Accounts	FULL last accounts made up to 31 mars 2019
Activité (Code NAF)	46460 - Commerce de gros de produits pharmaceutiques
Noms Précédents	Dwsco 2160 Limited
KYC Check KYC checks will cover 240 countries and 40 languages for both corporates and individuals: PEP - Any individual that is considered a Politically Exposed Person, from Head of State to Members of Parliament, Members of the Board of State Owned Enterprises or Ambassadors and individuals representing their countries interests abroad. Sanction - Any individual or entity that is (or was) subject to sanctions by either the European Union, the United Nations, the United States Office of Foreign Assets Control and State Department and Her Majesty’s Treasury in the United Kingdom. Financial Regulator - Any individual or entity that has been fined or in some other way subject to action by any financial regulatory body. Law Enforcement - Any individual or entity that has been named in official documentation from Law Enforcement bodies such as the Police or any other agency such as Interpol or the FBI. Also those individuals and entities cited in Court and legal documents of that nature. Adverse Media - Any individual or entity that has been reported in global newspapers, news sites or other media as being involved in financial crime. Other country specific datasets	KYC / PEP / AML request

This data is incorrect?
Source: Company Register: Companies House (companieshouse.gov.uk)

go to our Search Engine

Quick access

Persons with Significant Control
Officers
Similar VAT Registered Companies

Persons with Significant Control (2)

Source: Companies House

GB Sumitomo Corporation Status: Active Notified: 06/04/2016 Companies House Number: 00000100 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

GB Sumitomo Corporation Europe Limited Status: Active Notified: 06/04/2016 Companies House Number: 01885117 Nature of Control

Ownership of shares – More than 25% but not more than 50%

Ownership of voting rights - More than 25% but not more than 50%

Officers (6)

Source: Companies House

Kitamura, Toshiya Chiyoda-Ku, 1008601 Tokyo, Japan Status: Active Notified: 22/01/2018 Date of Birth: 07/1965 Occupation: Business Man Role: Director Country of Residence: Japan Nationality: Japanese

Miyamoto, Yoshiaki 20126 Milano, Italy Status: Active Notified: 30/05/2017 Date of Birth: 11/1977 Occupation: Businessman Role: Director Country of Residence: Japan Nationality: Japanese

Morizumi, Harumasa Chiyoda-Ku, Tokyo, Japan Status: Active Notified: 01/01/2019 Date of Birth: 08/1967 Occupation: Director Role: Director Country of Residence: Japan Nationality: Japanese

Nishihara, Takahiro Duesseldorf, Germany Status: Active Notified: 20/04/2018 Date of Birth: 10/1962 Occupation: Director Role: Director Country of Residence: Germany Nationality: Japanese

Sumitomo Corporation Europe Ltd, Upper Thames Street, London, United Kingdom Status: Active Notified: 16/05/2003 Role: Secretary Nationality: British

Yamana, Takashi 68 Upper Thames Street, London, England Status: Active Notified: 03/04/2018 Date of Birth: 10/1963 Occupation: Ceo Role: Director Country of Residence: England Nationality: Japanese

Toutes les informations sur:

Summit Pharmaceuticals Europe Limited

Quick access

Persons with Significant Control (2)

Officers (6)